Literature DB >> 30859255

[Lateral pelvic lymph nodes in locally advanced rectal carcinoma-an underestimated site of recurrence?]

Cihan Gani1, Andreas Kirschniak2, Daniel Zips3.   

Abstract

Entities:  

Mesh:

Year:  2019        PMID: 30859255     DOI: 10.1007/s00066-019-01447-4

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  8 in total

1.  Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

Authors:  E Kapiteijn; C A Marijnen; I D Nagtegaal; H Putter; W H Steup; T Wiggers; H J Rutten; L Pahlman; B Glimelius; J H van Krieken; J W Leer; C J van de Velde
Journal:  N Engl J Med       Date:  2001-08-30       Impact factor: 91.245

2.  Neoadjuvant (Chemo)radiotherapy With Total Mesorectal Excision Only Is Not Sufficient to Prevent Lateral Local Recurrence in Enlarged Nodes: Results of the Multicenter Lateral Node Study of Patients With Low cT3/4 Rectal Cancer.

Authors:  Atsushi Ogura; Tsuyoshi Konishi; Chris Cunningham; Julio Garcia-Aguilar; Henrik Iversen; Shigeo Toda; In Kyu Lee; Hong Xiang Lee; Keisuke Uehara; Peter Lee; Hein Putter; Cornelis J H van de Velde; Geerard L Beets; Harm J T Rutten; Miranda Kusters
Journal:  J Clin Oncol       Date:  2018-11-07       Impact factor: 44.544

Review 3.  Embryology and anatomy of the rectum.

Authors:  R J Heald; B J Moran
Journal:  Semin Surg Oncol       Date:  1998-09

4.  Total Mesorectal Irradiation: The "Next Step" in the Multidisciplinary Management of Rectal Adenocarcinoma?

Authors:  Oriol Pares; Ines Santiago; Carlo Greco; Richard Heald
Journal:  Dis Colon Rectum       Date:  2016-12       Impact factor: 4.585

5.  Mesorectal Excision With or Without Lateral Lymph Node Dissection for Clinical Stage II/III Lower Rectal Cancer (JCOG0212): A Multicenter, Randomized Controlled, Noninferiority Trial.

Authors:  Shin Fujita; Junki Mizusawa; Yukihide Kanemitsu; Masaaki Ito; Yusuke Kinugasa; Koji Komori; Masayuki Ohue; Mitsuyoshi Ota; Yoshihiro Akazai; Manabu Shiozawa; Takashi Yamaguchi; Hiroyuki Bandou; Kenji Katsumata; Kohei Murata; Yoshihito Akagi; Nobuhiro Takiguchi; Yoshihisa Saida; Kenichi Nakamura; Haruhiko Fukuda; Takayuki Akasu; Yoshihiro Moriya
Journal:  Ann Surg       Date:  2017-08       Impact factor: 12.969

6.  Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997.

Authors:  R J Heald; B J Moran; R D Ryall; R Sexton; J K MacFarlane
Journal:  Arch Surg       Date:  1998-08

7.  Patterns of recurrence in adenocarcinoma of the rectum and rectosigmoid treated with surgery alone: implications in treatment planning with adjuvant radiation therapy.

Authors:  W M Mendenhall; R R Million; W W Pfaff
Journal:  Int J Radiat Oncol Biol Phys       Date:  1983-07       Impact factor: 7.038

8.  Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial.

Authors:  David Sebag-Montefiore; Richard J Stephens; Robert Steele; John Monson; Robert Grieve; Subhash Khanna; Phil Quirke; Jean Couture; Catherine de Metz; Arthur Sun Myint; Eric Bessell; Gareth Griffiths; Lindsay C Thompson; Mahesh Parmar
Journal:  Lancet       Date:  2009-03-07       Impact factor: 79.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.